Clinical Trials on Diffuse Large B-Cell Leukemia
Total 6006 results
-
Nordic Lymphoma GroupRoche Pharma AGRecruitingDiffuse Large B Cell Lymphoma | DLBCLFinland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
-
University of Wisconsin, MadisonMedical College of WisconsinRecruitingCancer | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
Xynomic Pharmaceuticals, Inc.RecruitingDiffuse Large B-cell Lymphoma (DLBCL)China
-
Antengene CorporationTerminatedRelapsed/Refractory Diffuse Large B-cell LymphomaChina
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Fogarty...CompletedHIV | Diffuse Large B-cell LymphomaMalawi
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityCompletedRefractory Diffuse Large B-Cell LymphomaChina
-
The Lymphoma Academic Research OrganisationHoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma CD20 PositiveFrance, Belgium
-
Neumedicines Inc.UnknownLymphoma, Large B-Cell, Diffuse (DLBCL)
-
National Cancer Institute (NCI)RecruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | AIDS-Related LymphomaUnited States
-
BeBetter Med IncRecruitingRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
University Medical Center GroningenStichting Hemato-Oncologie voor Volwassenen NederlandRecruitingNHL | DLBCL - Diffuse Large B Cell LymphomaNetherlands
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaboratorsRecruitingGastric Diffuse Large B-cell LymphomaTaiwan
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
BeiGeneCompletedRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyActive, not recruitingDiffuse Large B Cell Lymphoma | Transformed LymphomaUnited States
-
Barbara Ann Karmanos Cancer InstituteWithdrawnRelapsed Diffuse Large B-cell LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States
-
Jiangsu Cancer Institute & HospitalUnknownDiffuse Large B-Cell Lymphoma (DLBCL)China
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-cell Lymphoma | Rituximab | ToripalimabChina
-
Hospital Universitario Principe de AsturiasUnknownDiffuse Large B-Cell Lymphoma (DLBCL)Spain
-
Memorial Sloan Kettering Cancer CenterTakedaActive, not recruitingWaldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Burkitt's Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Indolent Non-Hodgkin Lymphoma | Primary CNS Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B Cell LymphomaUnited States
-
Calibr, a division of Scripps ResearchEnrolling by invitationTransformed Follicular Lymphoma | Burkitt Lymphoma | Waldenstrom Macroglobulinemia | Lymphoplasmacytic Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Primary Mediastinal Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Mantle Cell Lymphoma (MCL) | Follicular... and other conditionsUnited States
-
Hoffmann-La RocheCompletedDiffuse Large B-cell Lymphoma | High-Grade B-cell LymphomaUnited States, Spain, Australia, Denmark
-
Zhejiang UniversityShanghai First Song Therapeutics Co., LtdNot yet recruitingHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Gray Zone Lymphoma | NK/T Cell Lymphoma | Peripheral T Cell Lymphoma, Unspecified | Mediastinal B-Cell Diffuse Large Cell LymphomaChina
-
LanZhou UniversityBeigene (Beijing) Biotechnology Co., LtdNot yet recruitingDiffuse Large B-cell Lymphoma (DLBCL)China
-
Seoul National University HospitalRecruitingRelapsed/Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingDiffuse Large B Cell Lymphoma (DLBCL)China
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; Taipei Veterans... and other collaboratorsNot yet recruitingRefractory Diffuse Large B-cell Lymphoma
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
Nanjing Yoko Biomedical Co., Ltd.RecruitingDiffuse Large B-Cell Lymphoma, Unspecified SiteChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma UnclassifiableUnited States
-
Kite, A Gilead CompanyGenentech, Inc.CompletedRefractory Diffuse Large B Cell LymphomaUnited States
-
Philogen S.p.A.Terminated
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma，DLBCLChina
-
Catherine BollardActive, not recruitingHodgkin Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
AmgenCompletedHigh-risk Diffuse Large B-Cell LymphomaUnited States, Canada, Germany, Spain, France, United Kingdom
-
Ruijin HospitalUnknownDiffuse Large B-Cell Lymphoma RefractoryChina
-
Samsung Medical CenterCompletedDiffuse Large B-cell Lymphoma (DLBCL)Korea, Republic of
-
Biomea Fusion Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Cancer | Progression | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Plasma Cell Myeloma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Refractory | Myeloma, Plasma-Cell | Myelomatosis | Acute Mixed-Phenotype...United States, Spain, Netherlands, Greece, Italy
-
Acerta Pharma BVActive, not recruitingActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)United States, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaHoffmann-La RocheActive, not recruitingDiffuse Large B Cell Lymphoma | High-grade B-cell LymphomaAustralia
-
National Cancer Institute (NCI)CompletedStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedStage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Diffuse Large Cell Lymphoma | Contiguous Stage II Adult Diffuse Large Cell Lymphoma | Noncontiguous Stage II Adult Diffuse Large Cell LymphomaUnited States
-
Nantes University HospitalCompletedLymphoma, Large-Cell, DiffuseFrance
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large-Cell LymphomaFrance, Belgium
-
Lymphoma Study AssociationCompletedLymphoma, Large-Cell, DiffuseUnited States, Australia, Belgium, Czechia, Finland, Germany, Israel, Sweden, Switzerland, United Kingdom
-
Lymphoma Study AssociationFondation ARCTerminatedLymphoma, Large-Cell, DiffuseFrance, Switzerland, Belgium
-
Lymphoma Study AssociationAmgenTerminatedDiffuse Large Cell LymphomaFrance, Belgium, Switzerland
-
Astellas Pharma IncTerminatedLymphoma, Large-Cell, Diffuse | Lymphoma, B-Cell RefractoryFrance, Spain, United States, Canada
-
GlaxoSmithKlineCompletedLymphoma, Large-Cell, DiffuseUnited States, Netherlands, Estonia, Spain, United Kingdom, Sweden, Israel, Poland, Belgium, Korea, Republic of, Singapore, Austria, Germany, Finland, Ireland, Thailand, China, Russian Federation, Czech Republic, Argentina, Denmark and more